Trial intelligence / Profile preview

IG-RD-001 (Ze-339) vs Desloratadine in Seasonal Allergic Rhinitis

NCT00862225Phase 2Completed

Sponsor
Max Zeller Söhne
Start
Jan 2008
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Tesalin N in seasonal allergic rhinitis (SAR), sponsored by Max Zeller Söhne. Started Jan 2008; status: completed.

02

Drugs

Tesalin N
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00862225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00862225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call